Dr. Asongwe L A Tantoh is a clinical scientist and immunologist with doctoral degree obtained from the University of Cape Town in collaboration with the Council for Scientific and Industrial Research (CSIR) in Pretoria, South Africa. He was a vital component of a "A" team that was in charge of designing, creating, and validating the first high-throughput, high-content microarray cell-based screening technology in Africa. He worked with the Emerging Research group (ERA) after completing his postdoctoral studies at the CSIR, where one of his primary duties was to instruct other researchers on the operational aspects of the screening platform. He started off as a researcher at the CSIR, where he is still employed now. Dr. Tantoh works as a researcher in the small molecule microarray screening, biotechnology, system biology domains, disease profiling, and drug discovery. He is the principal investigator for the CSIR Miniaturized Array-Based Profiling Technology. His research aims to develop novel, miniature small molecule screening technology that can be used to investigate different disease models and improve the current, inadequate treatment management of infectious diseases such as AMR, HSV, HCV, and HIV/AIDS.
Ability to lead, plan, complete projects in time, based on experience gained working as a postdoctoral researcher
SLW File Number 3960.004US1 Title TRANSFECTION SYSTEMS, METHODS AND MEDIA
Currently training two Laboratory Technicians and two PhD students, Ms Mpumi Mthimkulu, University of Cape Town and Mr Malose Mokwena, University of Witwaterstrand) on how to perform High-throughput Microarray Screening to address specific biological questions as well as developing novel but specific applications using the microarray technology for biological target identification.
Dr Zandile P Mahlangu, University of Cape Town, Identification of new therapeutic compounds against carbapenemase-producing Klebsiella pneumoniae using a novel agar-based high-throughput microarray compound screening approach., 2023